# Grok-4.1-Fast Review

**Role:** External referee review
**Model:** x-ai/grok-4.1-fast
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T17:04:46.348567
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 15051 in / 2627 out
**Response SHA256:** 386e8fd032e66c6b

---

## 1. IDENTIFICATION AND EMPIRICAL DESIGN (CRITICAL)

The identification strategy is credible and sophisticated for a causal claim of UK-specific Brexit spillovers on French housing prices via pre-existing networks. The baseline continuous-treatment DiD (Eq. 1, p. 7) uses département-level median log prices, with Exposure_d (SCI, census stock, or residualized) × Post_t (2016Q3+), département FE, and quarter FE. Post-treatment timing aligns with referendum (Jun 2016) and sterling shock (10% GBP/EUR drop Q2-Q4 2016); data coverage (2014-2023) has no gaps post-treatment.

Key innovations address threats transparently:
- **Endogenous SCI**: 2021 SCI risks post-treatment bias; pre-determined 2016 census UK stock (Jan 1 ref. date, pre-referendum; p. 8, Table 1) validates as proxy (similar β=0.011, p=0.001 in Table 2 col. 2 vs. SCI col. 1).
- **Cosmopolitan confounding**: Residualized SCI (projected on DE/CH SCI, baseline price/coast/transactions; R²≈0.20, p. 8) yields insignificant β=0.010 (p=0.43, Table 2 col. 3).
- **Generic international trends**: Triple-diff (Eq. 2, p. 9; Table 3) exploits House_p heterogeneity (UK buyers favor rural maisons, not appartements), with dept×type, quarter×type, and crucially dept×quarter FE absorbing all dept-time shocks. Identifies from within-dept/quarter house-apartment gap widening in high-UK areas post-Brexit.

Assumptions explicit/testable:
- Parallel trends: Event studies (Figs. 1-2; borderline p=0.038 SCI/0.048 stock in baseline DiD); house-apartment *gap* event study (Fig. 3, p=0.240 stock) far more reassuring for triple-diff.
- No anticipation/SUTVA: Census pre-ref.; LOO (Fig. 6) rules out single-dept drivers; spatial spillovers bias toward zero.
- German placebo: Null in triple-diff (β=0.008, p=0.66, Table 3 col. 4; horse-race col. 5 strengthens UK β=0.032, p=0.13), vs. large in baseline (β=0.043, p=0.01, Table 2 col. 5)—key win.

Threats discussed comprehensively (p. 10-11): reverse causality (census fixes), compositional/transaction bias (median outcome, type split), COVID (short window robust). No major gaps; timing coherent (no impossible post-treatment). Minor concern: Continuous treatment assumes no dynamic heterogeneity effects (noted p. 11; event studies mitigate).

## 2. INFERENCE AND STATISTICAL VALIDITY (CRITICAL)

Inference valid throughout. Dept-clustered SEs reported consistently (e.g., Tables 2-3,5-7); p-values/stars standard (*p<0.1, etc.). CIs implicit in SEs/shading (Figs. 1-6). Sample sizes explicit/coherent: 3510 dept-qtr obs baseline (96 depts×40 qtrs, missing low-transaction cells); 7010 effective in triple (after singletons dropped); 3209/6412 for census-restricted (89 depts).

No TWFE staggered issues (national uniform shock). RI permutation (Fig. 5, 2000 perms) and LOO (Fig. 6) robust to clustering. Event-study joint F-tests for pre-trends. Two-way clustering mentioned as similar (p. 22). Power low in triple (acknowledged p. 19; demanding FEs), but no manipulation checks needed (no RDD). All main estimates uncertainty-quantified; passes.

## 3. ROBUSTNESS AND ALTERNATIVE EXPLANATIONS

Core results robust to contained alternatives, but demanding specs (trends, pre-COVID) attenuate/eliminate:
- Sample: No Île-de-France/Corsica (Table 5 cols. 2-3); 2014-2018 (col. 4, β=0.007, p=0.005 census baseline).
- Specs: Binary top-quintile (col. 5, p=0.19); trends kill baseline (Table 2 col. 6, β=-0.001, p=0.91; Table 5 col. 6).
- Placebos/falsification: German triple null; RI p<<0.01 baseline census.
- Mechanisms: Exchange rate × exposure negative (Table 6, β=-0.056 stock, p=0.004)—consistent with demand dampening—but German also sig (p=0.005), so inconclusive. Geo-het (Table 7): Stronger Channel (β=0.014, p<0.001).

Distinguishes reduced-form (price div.) from mechanisms (exchange tentative). COVID limitation clear (pre-2019 triple β≈0, p=0.97, p. 27); external validity bounded to rural houses/UK networks. No over-reliance on falsifications.

## 4. CONTRIBUTION AND LITERATURE POSITIONING

Clear differentiation: Methodological advance for SCI/shift-share designs (cosmopolitan bias template: census proxy, residualize, triple-diff; cites Borusyak2022, Goldsmith2020, Adao2019). Prior SCI housing (Bailey2018house, SableGreenberg2023) naively cross-sectional; this diagnoses failures.

Brexit lit gap: Cross-border housing novel (vs. trade Born2019, uncertainty Hassan2024); closest Mastrosavvas2024 (UK-internal). Foreign demand (Saiz2010) lacks nationality ID—here indirect via networks/type.

Lit sufficient (method + policy); no major omissions. Suggest adding: GoodmanBello2023 (SCI migration validation, for census-SCI correlation); AutorDorn2020 (shift-share networks pitfalls).

## 5. RESULTS INTERPRETATION AND CLAIM CALIBRATION

Conclusions match evidence: Modest genuine UK channel (census baseline β=0.011, ~1pp log price per log-stock unit), but attenuates with trends/residualize; triple right sign/placebo (β=0.003-0.029, p=0.10-0.18) imprecise. No overclaim—emphasizes methodological template (p. 1,27-28); policy minimal ("spillovers"). Magnitudes consistent (e.g., Tables 2-3); no text-result contradictions (e.g., admits German baseline dominance p. 24). COVID confound flagged (p. 27); honest totality: "suggestive but not definitive" (p. 27).

## 6. ACTIONABLE REVISION REQUESTS

1. **Must-fix issues before acceptance**
   - Quantify triple-diff power: Low power drives p≈0.10 (p. 19); report minimum detectable effect or power curves for baseline/triple (why: Ensures transparency on precision limits; fix: Simulate under alt. effect sizes using observed residual variance).
   - Pre-2019 triple insignificant (p=0.97, p. 27): Report full pre-/post-COVID splits for all specs (Tables 2-3 extended); clarify if signal COVID-driven (why: Undermines Brexit causal claim; fix: Add Table col. with 2014-2019 sample, discuss).

2. **High-value improvements**
   - Event-study full triple-diff: Figs. 2-3 omit dept×qtr FE (noted p. 20); stack pre/post or use Callaway2021 aggregator (why: Visual pre-trend/ dynamic confirmation critical; fix: Append Fig. with honest SEs noting collinearity).
   - Exchange placebo deeper: German sig in Table 6; test Swiss/Netherlands (why: Strengthens mechanism; fix: Extend Table 6).
   - Falsification expansion: Pre-trend F-tests all exposures (not just gap; why: Completes battery; fix: Table with SCI/resid./DE).

3. **Optional polish**
   - Aggregation error in census: Note bassin→dept MAE (why: Bounds attenuation; fix: Sensitivity to raw bassin FEs if feasible).
   - Exchange interaction full post-period only: Confirm no pre-trend (why: Clean mechanism; fix: Event-study version).

## 7. OVERALL ASSESSMENT

**Key strengths**: Innovative triple-diff + placebos credibly isolates UK channel; pre-determined census validates SCI; exhaustive diagnostics (RI/LOO/events); exceptionally honest calibration amid weak power/attenuation.

**Critical weaknesses**: Baseline census robust but trends kill (p=0.91); triple imprecise (p>0.10) and pre-COVID null; residualized insignificant—effects modest/suggestive, not definitive. COVID confound unresolved in full sample.

**Publishability after revision**: High—methodological template ideal for top general-interest/AEJ:Policy; substance sound, revisions contained to power/COVID clarity.

DECISION: MINOR REVISION